Sol-Gel Technologies - 6 Year Stock Price History | SLGL

Historical daily share price chart and data for Sol-Gel Technologies since 2018 adjusted for splits and dividends. The latest closing stock price for Sol-Gel Technologies as of November 01, 2024 is 0.51.
  • The all-time high Sol-Gel Technologies stock closing price was 17.15 on December 31, 2019.
  • The Sol-Gel Technologies 52-week high stock price is 1.58, which is 209.8% above the current share price.
  • The Sol-Gel Technologies 52-week low stock price is 0.33, which is 35.3% below the current share price.
  • The average Sol-Gel Technologies stock price for the last 52 weeks is 0.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sol-Gel Technologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 0.8426 1.2201 1.5000 0.3660 0.5101 -53.84%
2023 3.0300 4.7300 5.3200 0.9202 1.1050 -75.77%
2022 5.9503 7.8200 8.2100 4.1000 4.5599 -38.38%
2021 10.2341 9.9300 15.4900 6.5700 7.4000 -24.41%
2020 8.8386 15.7500 15.7500 5.8800 9.7900 -42.92%
2019 8.0379 6.3500 17.1500 5.7100 17.1500 184.88%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.014B $0.002B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00